Author
@BiopharmIQ BiopharmIQ
Institutional-grade biotech catalyst and hedge-fund 13F data feed
Publishes a high-volume biotech intelligence feed: clinical/
trader score
·
hit rate
·
mean α
·
signals 14d
174
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Not yet in the scored-bets universe (fewer than 20 scoreable calls). Their last-14d mentions, direction-adjusted, have moved +9.3% since posting (mean over 60 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-02 | UTHR | @BiopharmIQ | -0.05 | UTHR completed acquisition of Thymmune Tx with $140M upfront and up to $160M earn-outs. | — | tweet ↗ |
| 2026-07-02 | · | @BiopharmIQ | · | Claims BPIQ model portfolios have outperformed XBI and IBB since 2023. | · | tweet ↗ |
| 2026-07-02 | ABVX | @BiopharmIQ | +0.45 | ABVX described as standout mover after positive data and $920M financing. | — | tweet ↗ |
| 2026-07-02 | TENX | @BiopharmIQ | +0.25 | Biotech catalyst roundup cites clinical data, approval, FDA news, and financing. | · | tweet ↗ |
| 2026-07-02 | HCM | @BiopharmIQ | +0.50 | Biotech catalyst roundup cites clinical data, approval, FDA news, and financing. | · | tweet ↗ |
| 2026-07-02 | ABVX | @BiopharmIQ | +0.10 | Biotech catalyst roundup cites clinical data, approval, FDA news, and financing. | — | tweet ↗ |
| 2026-07-02 | VRTX | @BiopharmIQ | +0.50 | Biotech catalyst roundup cites clinical data, approval, FDA news, and financing. | — | tweet ↗ |
| 2026-07-02 | TENX | @BiopharmIQ | +0.25 | Biotech midday mover list with catalysts and percentage moves. | · | tweet ↗ |
| 2026-07-02 | HCM | @BiopharmIQ | +0.35 | Biotech midday mover list with catalysts and percentage moves. | · | tweet ↗ |
| 2026-07-02 | AZN | @BiopharmIQ | +0.15 | Biotech midday mover list with catalysts and percentage moves. | — | tweet ↗ |
| 2026-07-02 | ABVX | @BiopharmIQ | +0.25 | Biotech midday mover list with catalysts and percentage moves. | — | tweet ↗ |
| 2026-07-02 | ARCT | @BiopharmIQ | +0.20 | Biotech midday mover list with catalysts and percentage moves. | · | tweet ↗ |
| 2026-07-02 | RHHBY | @BiopharmIQ | +0.20 | Biotech midday mover list with catalysts and percentage moves. | — | tweet ↗ |
| 2026-07-01 | SXTP | @BiopharmIQ | +0.10 | Biotech catalyst watchlist with 52 Q3 readouts and named trial dates. | · | tweet ↗ |
| 2026-07-01 | CNTB | @BiopharmIQ | +0.10 | Biotech catalyst watchlist with 52 Q3 readouts and named trial dates. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.